6650--VISN 8 Whole Blood Glucose Monitoring
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically Network Contracting Office 8 (NCO 8), is soliciting proposals for a Blanket Purchase Agreement (BPA) for Point of Care Whole Blood Glucose Monitoring systems for VISN 8 facilities. This UNRESTRICTED opportunity covers equipment, reagents, supplies, service, and training under a Cost Per Test (CPT) model. Proposals are due June 4, 2026, at 1:00 PM EDT.
Scope of Work
This BPA requires the provision of comprehensive Point of Care Whole Blood Glucose monitoring systems, including analyzers, downloaders, meters, charging stations, and associated consumables (reagents, standards, quality controls, supplies). Services include equipment rental, 24/7 service maintenance with a 48-hour on-site response, network support, installation, training, software/middleware support, and upgrades.
Key technical requirements specify FDA-approved devices, HL7 interface compatibility with VISN 8 UniPOC/RALS middleware and EHR systems, scanning capability, ergonomic design, rapid results (≤5 seconds), and compliance with VA information security directives. Training includes on-site support for operator training and validation studies.
Contract Details
- Contract Type: Blanket Purchase Agreement (BPA)
- Period of Performance: A base year (July 1, 2026 - June 30, 2027) plus four (4) option years, extending through June 30, 2031.
- Estimated Value: The ceiling limit for this BPA is $3,545,540.60. Individual BPA Orders may reach $12,555.00.
- Pricing: Based on a Cost Per Test (CPT) model, which includes equipment use, all consumables, and support.
- Set-Aside: UNRESTRICTED, with options for small business set-asides.
- NAICS Code: 325413 (In-Vitro Diagnostic Substance Manufacturing).
- Place of Performance: Various VISN 8 facilities, including James A. Haley Veterans Hospital and Clinics, Bay Pines, Miami, West Palm Beach, North Florida/South Georgia, VA Caribbean, and Orlando.
Submission & Evaluation
- Submission Deadline: June 4, 2026, 1:00 PM EDT.
- Submission Method: Email to Paul.Jarrett@va.gov.
- Evaluation Factors: Proposals will be evaluated based on Technical Acceptability (go/no-go), Past Performance (more important than Price), and Price. Offerors must provide a detailed technical narrative, past performance information (optional), and a complete price quote.
Key Clarifications
An amendment clarified several points:
- Alternative BPA term structures will be considered.
- Offerors may submit proposals using their standard commercial agreement terms, provided all required FAR/VAAR clauses are incorporated and exceptions are clearly identified.
- The requirement for FIPS 140-2 compliant meters is revised to a notification requirement when such capability becomes available, acknowledging current market limitations.
- The estimated annual strip usage is 1,676,170.